Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb 15;2012(2):CD007288.
doi: 10.1002/14651858.CD007288.pub2.

Hyperbaric oxygen therapy for Bell's palsy

N Julian Holland  1 , Jonathan M Bernstein, John W Hamilton
Affiliations

Hyperbaric oxygen therapy for Bell's palsy

N Julian Holland et al. Cochrane Database Syst Rev. .

Abstract

Background: Bell's palsy is an idiopathic, acute unilateral facial weakness that evolves rapidly and is maximal within two days. Moderate ear discomfort, sensitivity to sound and reduced tearing may occur.

Objectives: To assess the effects of hyperbaric oxygen therapy on recovery of facial function in adults with moderate to severe Bell's palsy.

Search methods: We searched the Cochrane Neuromuscular Disease Group Specialized Register (January 2012), CENTRAL (2011, Issue 4), MEDLINE (January 1966 to January 2012), EMBASE (January 1980 to January 2012), CINAHL (1937 to January 2012), AMED (1985 to January 2012), LILACS (January 1982 to January 2012). In addition we made a systematic search for relevant controlled trials in specific hyperbaric literature sources.

Selection criteria: Randomised controlled trials or quasi-randomised controlled trials of adults (over 16 years of age) undergoing hyperbaric oxygen therapy for moderate to severe Bell's palsy. We considered studies to be of sufficient quality for inclusion in the review only if there was blinding in the assessment of the facial palsy grade. We planned to include studies of HBOT used as adjuvant therapy, or in addition to routine medical therapy (including corticosteroids or antivirals, or both). Both treatment and control groups were to receive the same baseline therapy. HBOT had to be delivered at concentrations greater than or equal to 1.2 ATA in a hyperbaric oxygen chamber as a series of dives of 30 to 120 minutes.

Data collection and analysis: Two reviewers independently assessed eligibility and study quality and extracted data. We contacted study authors for additional information.

Main results: Our searches found no randomised controlled trials or quasi-randomised controlled trials that met the eligibility criteria for this review.There is very low quality evidence from one randomised trial involving 79 participants with acute Bell's palsy, but this study was excluded as the outcome assessor was not blinded to treatment allocation and thus did not meet pre-defined eligibility criteria. The trial compared 42 people who received hyperbaric oxygen therapy (2.8 atmospheres for 60 minutes twice daily, five days per week until the facial palsy resolved; maximum 30 'dives') and placebo tablets with 37 people who received placebo hyperbaric oxygen therapy (achieving only a normal partial pressure of oxygen) and prednisone (40 mg twice daily, reducing over eight days). Facial function recovered in more participants treated with hyperbaric oxygen therapy than with prednisone (hyperbaric oxygen therapy, 40/42 (95%); prednisone, 28/37 (76%); risk ratio 1.26, 95% CI 1.04 to 1.53). There were no reported major complications and all participants completed the trial.

Authors' conclusions: Very low quality evidence from one trial suggests that hyperbaric oxygen therapy may be an effective treatment for moderate to severe Bell's palsy, but this study was excluded as the outcome assessor was not blinded to treatment allocation. Further randomised controlled trials are needed.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest.

Update of

References

References to studies excluded from this review

Litavrin 1985 {published data only}
    1. Litavrin AF, Platonova GB, Gribanov VA. Hyperbaric oxygenation in the treatment of facial neuritis. Zhurnal Nevropatologii i Psikhiatrii Imeni S. S. Korsakova 1985;85(4):528‐31. [PUBMED: 3890428] - PubMed
Makishima 1998 {published data only}
    1. Makishima K, Yoshida M, Kuroda Y, Konda N, Ikebe E. Hyperbaric oxygenation as a treatment for facial palsy. Advances in Oto‐Rhino‐Laryngology 1998;54:110‐8. [PUBMED: 9547881] - PubMed
Racic 1997 {published data only}
    1. Racic G, Denoble PJ, Sprem L, Bojic L, Bota B. Hyperbaric oxygen as a therapy of Bell's palsy. Undersea and Hyperbaric Medicine 1997;24(1):35‐8. [PUBMED: 9068154] - PubMed

Additional references

Bennett 2002
    1. Brubakk AO, Neuman TS. Bennett and Elliotts's Physiology and Medicine of Diving. 5th Edition. Edinburgh UK: Saunders Ltd, 2003.
Blanshard 1996
    1. Blanshard J, Toma A, Bryson P, Williamson P. Middle ear barotrauma in patients undergoing hyperbaric oxygen therapy. Clinical Otolaryngology and Allied Sciences 1996;21(5):400‐3. [EMBASE: 1996345071; PUBMED: 8932942] - PubMed
DerSimonian 1986
    1. DerSimonian R, Laird N. Meta‐analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177‐88. [PUBMED: 3802833] - PubMed
Engström 2008
    1. Engström M, Berg T, Stjernquist‐Desatnik A, Axelsson S, Pitkäranta A, Hultcrantz M, et al. Prednisolone and valaciclovir in Bell’s palsy: a randomised, double‐blind, placebo‐controlled, multicentre trial. Lancet 2008;7(11):993‐1000. [PUBMED: 18849193] - PubMed
Engström 2009
    1. Engström M, Berg T, Stjernquist‐Desatnik A, Axelsson S, Pitkäranta A, Hultcrantz M, et al. Is antiviral medication for severe Bell's palsy still useful? – Authors' reply. Lancet Neurology 2009;8(6):509‐10. [PUBMED: 19446267] - PubMed
Fisch 1981
    1. Fisch U. Surgery for Bell's palsy. Archives of Otolaryngology 1981;107(1):1‐11. [PUBMED: 7469872] - PubMed
Fisch 1983
    1. Fisch U, Felix H. On the pathogenesis of Bell's palsy. Acta Oto‐Laryngologica 1983;95(5‐6):532‐8. [PUBMED: 6880661] - PubMed
Fisch 1984
    1. Fisch U. Prognostic value of electrical tests in acute facial paralysis. The American Journal of Otology 1984;5(6):494‐8. [PUBMED: 6393772] - PubMed
Gilden 1994
    1. Gilden DH, Wright RR, Schneck SA, Gwaltney JM Jr, Mahalingam R. Zoster sine herpete, a clinical variant. Annals of Neurology 1994;35(5):530‐3. [PUBMED: 8179298] - PubMed
Hato 2007
    1. Hato N, Yamada H, Kohno H, Matsumoto S, Honda N, Gyo K, et al. Valacyclovir and prednisolone treatment for Bell's palsy: a multicenter, randomized, placebo‐controlled study. Otology and Neurotology 2007;28(3):408‐13. [PUBMED: 17414047] - PubMed
Higgins 2008
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Available from www.cochrane‐handbook.org.
Holland 2004
    1. Holland NJ, Weiner GM. Recent developments in Bell's palsy. BMJ 2004;329(7465):553‐7. [PUBMED: 15345630] - PMC - PubMed
Holland 2010
    1. Holland J, Bernstein J. Bell's palsy. Clinical Evidence (Online) 2011;Mar 7:1204. - PMC - PubMed
House 1985
    1. House JW, Brackmann DE. Facial nerve grading system. Otolaryngology ‐ Head and Neck Surgery 1985;93(2):146‐7. [PUBMED: 3921901] - PubMed
Hunt 1972
    1. Hunt TK, Niinikoski J, Zederfeldt B. Role of oxygen in repair processes. Acta Chirurgica Scandinavica 1972;138(2):109‐10. [PUBMED: 5036406] - PubMed
Jain 1990
    1. Jain KK. Textbook of hyperbaric medicine. Toronto: Hogrefe & Huber Publishers, 1990.
Kindwall 1994
    1. Kindwall EP. Hyperbaric medicine practice. Flagstaff AZ: Best Publishing Company, 1994.
Kindwall 2003
    1. Kindwall EP. Unexpected odyssey: from merchant sailor to hyperbaric physician. Flagstaff AZ: Best Publishing, 2003.
Lewis 1958
    1. Lewis GW. Zoster sine herpete. British Medical Journal 1958;2(5093):418‐21. [PUBMED: 13560886] - PMC - PubMed
Linder 2005
    1. Linder T, Bossart W, Bodmer D. Bell's palsy and herpes simplex virus: fact or mystery?. Otology and Neurotology 2005;26(1):109‐13. [PUBMED: 15699730] - PubMed
Lockhart 2009
    1. Lockhart P, Daly F, Pitkethly M, Comerford N, Sullivan F. Antiviral treatment for Bell's palsy (idiopathic facial paralysis). Cochrane Database of Systematic Reviews 2009, Issue 7. [DOI: 10.1002/14651858.CD001869.pub4] - DOI - PubMed
Mader 1980
    1. Mader JT, Brown GL, Guckian JC, Wells CH, Reinarz JA. A mechanism for the amelioration by hyperbaric oxygen of experimental staphylococcal osteomyelitis in rabbits. Journal of Infectious Diseases 1980;142(6):915‐22. [PUBMED: 7462700] - PubMed
Marroni 1999
    1. Bakker DJ, LePéchon JC, Marroni A. Hyperbaric oxygen wound healing safety cost‐effectiveness. Flagstaff AZ: Best Publishing, 1998.
McAllister 2011
    1. McAllister K, Walker D, Donnan PT, Swan I. Surgical interventions for the early management of Bell's palsy. Cochrane Database of Systematic Reviews 2011, Issue 2. [DOI: 10.1002/14651858.CD007468.pub2] - DOI - PubMed
Murakami 1996
    1. Murakami S, Mizobuchi M, Nakashiro Y, Doi T, Hato N, Yanagihara N. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Annals of Internal Medicine 1996;124(1 Pt 1):27‐30. [PUBMED: 7503474] - PubMed
Phillips 2008
    1. Phillips JS, Jones SE. Hyperbaric oxygen as an adjuvant treatment for malignant otitis externa. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD004617.pub2] - DOI - PubMed
Pietersen 2002
    1. Pietersen E. Bell's palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngologica Supplementum 2002;549:4‐30. [PUBMED: 12482166] - PubMed
Pirone 1997
    1. Pirone C, Bullock M, Williamson J. Report of 1996 data from the international hyperbaric incident monitoring study (HIMS). Australia Safety Foundation, Royal Adelaide Hospital 1997.
Pitkaranta 2000
    1. Pitkäranta A, Piiparinen H, Mannonen L, Vesaluoma M, Vaheri A. Detection of human herpesvirus 6 and varicella‐zoster virus in tear fluid of patients with Bell's palsy by PCR. Journal of Clinical Microbiology 2000;38(7):2753‐5. [PUBMED: 10878079] - PMC - PubMed
Rowlands 2002
    1. Rowlands S, Hooper R, Hughes R, Burney P. The epidemiology and treatment of Bell's palsy in the UK. European Journal of Neurology 2002;9(1):63‐7. [PUBMED: 11784378 ] - PubMed
Salinas 2010
    1. Salinas RA, Alvarez G, Daly F, Ferreira J. Corticosteroids for Bell's palsy (idiopathic facial paralysis). Cochrane Database of Systematic Reviews 2010, Issue 17. [DOI: 10.1002/14651858.CD001942.pub4] - DOI - PubMed
Schmidbauer 1992
    1. Schmidbauer M, Budka H, Pilz P, Kurata T, Hondo R. Presence, distribution and spread of productive varicella zoster virus infection in nervous tissues. Brain 1992;115(Pt 2):383‐98. [PUBMED: 1318768] - PubMed
Sheffield 1998
    1. Sheffield PJ. Measuring tissue oxygen tension: a review. Undersea and Hyperbaric Medicine 1998;25(3):179‐88. [PUBMED: 9789339 ] - PubMed
Sullivan 2007
    1. Sullivan FM, Swan IR, Donnan PT, Morrison JM, Smith BH, McKinstry B, et al. Early treatment with prednisolone or acyclovir in Bell's palsy. New England Journal of Medicine 2007;357(16):1598‐607. - PubMed
Treweek 2006
    1. Treweek S, James PB. A cost analysis of monoplace hyperbaric oxygen therapy with and without recirculation. Journal of Wound Care 2006;15(6):235‐8. [PUBMED: 16802558] - PubMed
VanSwearingen 1996
    1. VanSwearingen JM, Brach JS. The Facial Disability Index: reliability and validity of a disability assessment instrument for disorders of the facial neuromuscular system. Physical Therapy 1996;76(12):1288‐98, discussion 1298‐300. [PUBMED: 8959998] - PubMed
Vrabec 2001
    1. Vrabec JT, Payne DA. Prevalence of herpesviruses in cranial nerve ganglia. Acta Oto‐Laryngologica 2001;121(7):831‐5. [PUBMED: 11718247] - PubMed

Publication types